Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: Comparison with sirolimus-eluting stent using optical coherence tomography

International Journal of Cardiovascular Imaging

Volumn 28, Issue 3, 2012, Pages 491-497

  Choi, Hyun Hee ^a   Kim, Jung Sun ^b   Yoon, Duck Hyoung ^a   Hong, Kyung Soon ^a   Kim, Tae Hoon ^b   Kim, Byeong Keuk ^b   Ko, Young Guk ^b   Choi, Donghoon ^b   Jang, Yangsoo ^b,c   Hong, Myeong Ki ^b,c  

^a Hallym University   (South Korea)

^b Yonsei University Health System   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Optical coherence tomography; Stent

Indexed keywords

EVEROLIMUS; RAPAMYCIN;

ADULT; ARTICLE; CARDIAC IMAGING; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; CORONARY STENT; DRUG ELUTING STENT; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; CORONARY THROMBOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; NEOINTIMA; PREDICTIVE VALUE OF TESTS; REGISTRIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SIROLIMUS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84861482050     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-011-9849-7     Document Type: Article

References (18)

1. Babapulle MN, Joseph L, Belisle P et al (2004) A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364:583-591 (Pubitemid 39094175)
2. Jeremias A, Sylvia B, Bridges J et al (2004) Stent thrombosis after successful sirolimus-eluting stent implantation. Circulation 109:1930-1932 (Pubitemid 38544480)
3. Kim U, Kim JS, Kim JS et al (2010) The initial extent of malapposition in ST-elevation myocardial infarction treated with drug-eluting stent: the usefulness of optical coherence tomography. Yonsei Med J 51:332-338
4. Matsumoto D, Shite J, Shinke T et al (2007) Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 28:961-967 (Pubitemid 47343895)
5. Takano M, Jang IK, Inami S et al (2008) In vivo comparison of optical coherence tomography and angioscopy for the evaluation of coronary plaque characteristics. Am J Cardiol 101:471-476 (Pubitemid 351199434)
6. Kim JS, Kim JS, Kim TH et al (2010) Comparison of neointimal coverage of sirolimus-eluting stent and paclitaxel- eluting stent using optical coherence tomography at 9 months after implantation. Circ J 74:320-326
7. Kim JS, Jang IK, Kim JS et al (2009) Optical coherence tomography evaluation of zotarolimus-eluting stents at 9 month follow up: comparison with sirolimus-eluting stents. Heart 95:1907-1912
8. Stone GW, Rizvi A, Newman W et al (2010) Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med 362:1663-1674
9. Costa RA, Lansky AJ, Mintz GS et al (2005) Angiographic results of the first huma experience with everolimus-eluting stents for the treatment of coronary lesion (the FUTURE I trial). Am J Cardiol 95:113-116 (Pubitemid 40051124)
10. Michael J, Gaku N, Finn AV et al (2008) Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 52:333-342 (Pubitemid 352001347)
11. Takano M, Inami S, Jang IK et al (2007) Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 99:1033-1038 (Pubitemid 46560470)
12. Finn AV, Joner M, Nakazawa G et al (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435-2441 (Pubitemid 46717966)
13. Tanigawa J, Barlis P, Dimopoulos K et al (2008) The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. Int J Cardiol 134:180-188
14. Kume T, Akasaka T, Kawamoto T et al (2006) Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 97:1713-1717 (Pubitemid 43817856)
15. Prati F, Regar E, Mintz GS et al (2010) Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. Eur Heart J 31:401-415
16. Jang IK, Bouma BE, Kang DH et al (2002) Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 39:604-609 (Pubitemid 34158155)
17. Barlis P, Regar E, Serruys PW et al (2010) An optical coherence tomography study of a biodegradable versus durable polymer-coated limus- eluting stent: a LEADERS trial sub study. Euro Heart J 31:165-176
18. Jensen LO, Thayssen P, Hanse HS et al (2010) A prospective randomized trial of everolimus-eluting and sirolimus- eluting stents in patients with coronary artery disease (SORT OUT IV trial). J Am Coll Cardiol 56(suppl B):xiii